NASDAQ:HYPR Hyperfine (HYPR) Stock Price, News & Analysis $1.05 +0.01 (+0.96%) (As of 03:07 PM ET) Add Compare Share Share Today's Range$1.02▼$1.0550-Day Range$0.90▼$1.2452-Week Range$0.76▼$2.11Volume32,975 shsAverage Volume104,465 shsMarket Capitalization$75.55 millionP/E RatioN/ADividend YieldN/APrice Target$1.43 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Hyperfine alerts: Email Address Hyperfine MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside38.3% Upside$1.43 Price TargetShort InterestBearish2.79% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.94Based on 2 Articles This WeekInsider TradingSelling Shares$2,883 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.57) to ($0.53) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.50 out of 5 starsMedical Sector482nd out of 927 stocksElectromedical Equipment Industry11th out of 22 stocks 3.2 Analyst's Opinion Consensus RatingHyperfine has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageHyperfine has received no research coverage in the past 90 days.Read more about Hyperfine's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.79% of the float of Hyperfine has been sold short.Short Interest Ratio / Days to CoverHyperfine has a short interest ratio ("days to cover") of 9.4.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldHyperfine does not currently pay a dividend.Dividend GrowthHyperfine does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HYPR. Previous Next 2.7 News and Social Media Coverage News SentimentHyperfine has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Hyperfine this week, compared to 1 article on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Hyperfine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,883.00 in company stock.Percentage Held by Insiders29.42% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.03% of the stock of Hyperfine is held by institutions.Read more about Hyperfine's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Hyperfine are expected to grow in the coming year, from ($0.57) to ($0.53) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Hyperfine is -1.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Hyperfine is -1.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHyperfine has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Hyperfine's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… Click here now and learn how to prepare. About Hyperfine Stock (NASDAQ:HYPR)Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Read More HYPR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HYPR Stock News HeadlinesSeptember 11, 2024 | businesswire.comResearchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® SystemAugust 28, 2024 | businesswire.comHyperfine, Inc. to Participate in Upcoming Investor ConferencesSeptember 16, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.August 9, 2024 | markets.businessinsider.comHyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue GuidanceAugust 9, 2024 | msn.comHyperfine beats top-line estimates; raises FY24 revenue outlookAugust 9, 2024 | seekingalpha.comHyperfine, Inc. (HYPR) Q2 2024 Earnings Call TranscriptMay 28, 2024 | businesswire.comHyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to IndiaMay 24, 2024 | investorplace.comThe Dollar Menu Portfolio: 7 Penny Stocks to Buy With Spare ChangeSeptember 16, 2024 | American Hartford Gold Group (Ad)Prepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.May 22, 2024 | businesswire.comHyperfine, Inc. to Present at the Jefferies Global Healthcare ConferenceMay 22, 2024 | finance.yahoo.comHyperfine, Inc. Celebrates ASNR 2024May 14, 2024 | msn.comHyperfine, Inc. (NASDAQ:HYPR) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comHyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and ChallengesMay 13, 2024 | investorplace.comHYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024May 13, 2024 | globenewswire.comHyperfine, Inc. Reports First Quarter 2024 Financial ResultsMay 10, 2024 | businesswire.comHyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European MarketsApril 23, 2024 | businesswire.comHyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical ConditionsApril 17, 2024 | msn.comHyperfine (HYPR) Price Target Decreased by 6.02% to 1.33See More Headlines Receive HYPR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/16/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:HYPR CUSIPN/A CIK1833769 Webhyperfine.io Phone866-796-6767FaxN/AEmployees190Year FoundedN/APrice Target and Rating Average Stock Price Target$1.43 High Stock Price Target$1.60 Low Stock Price Target$1.25 Potential Upside/Downside+38.3%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,240,000.00 Net Margins-347.05% Pretax Margin-347.05% Return on Equity-51.72% Return on Assets-46.14% Debt Debt-to-Equity RatioN/A Current Ratio8.08 Quick Ratio7.24 Sales & Book Value Annual Sales$11.94 million Price / Sales6.21 Cash FlowN/A Price / Cash FlowN/A Book Value$1.17 per share Price / Book0.88Miscellaneous Outstanding Shares71,950,000Free Float50,782,000Market Cap$74.11 million OptionableOptionable Beta0.83 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. R. Scott Huennekens CPA (Age 60)M.B.A., Executive Chairman Comp: $1.29MMs. Maria Sainz (Age 58)CEO, President & Director Comp: $340.24kDr. Jonathan M. Rothberg Ph.D. (Age 60)Founder & Vice Chairman Comp: $51.37kMr. Brett Hale (Age 50)Chief Administrative Officer, CFO, Chief Compliance Officer, Treasurer & Corporate Secretary Dr. Thomas Teisseyre Ph.D.Chief Operating OfficerMr. Chip Truwit FACRM.D., Vice President of Scientific AffairsMore ExecutivesKey CompetitorsDelcath SystemsNASDAQ:DCTHZynexNASDAQ:ZYXIAVITA MedicalNASDAQ:RCELNeuroPaceNASDAQ:NPCEProfound MedicalNASDAQ:PROFView All CompetitorsInsiders & InstitutionsThomas TeisseyreSold 2,746 sharesTotal: $2,883.30 ($1.05/share)Renaissance Technologies LLCSold 32,616 shares on 8/9/2024Ownership: 0.083%Thomas TeisseyreSold 2,753 sharesTotal: $2,422.64 ($0.88/share)Thomas TeisseyreSold 2,655 sharesTotal: $3,345.30 ($1.26/share)View All Insider TransactionsView All Institutional Transactions HYPR Stock Analysis - Frequently Asked Questions How have HYPR shares performed this year? Hyperfine's stock was trading at $1.12 at the beginning of 2024. Since then, HYPR stock has decreased by 8.0% and is now trading at $1.03. View the best growth stocks for 2024 here. How were Hyperfine's earnings last quarter? Hyperfine, Inc. (NASDAQ:HYPR) announced its quarterly earnings data on Thursday, August, 8th. The company reported ($0.14) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.14). The company earned $3.63 million during the quarter, compared to analysts' expectations of $3.15 million. Hyperfine had a negative net margin of 347.05% and a negative trailing twelve-month return on equity of 51.72%. Who are Hyperfine's major shareholders? Hyperfine's top institutional investors include Renaissance Technologies LLC (0.08%). Insiders that own company stock include Hc Sponsor Llc, Jonathan M Rothberg, Alok Gupta, Neela Paykel, Thomas Teisseyre and Khan Siddiqui. View institutional ownership trends. How do I buy shares of Hyperfine? Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HYPR) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersMore Than 30 Federal Agencies Buy From This Cybersecurity TechIn January of 2022 Ukraine was hit by an especially nasty piece of malware, named WhisperGate. By then Ukra...Capital Trends | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
